Toward molecular imaging-driven drug development in oncology

Area of Science:

• Oncology
• Molecular Imaging
• Pharmacodynamics

Background:

• The pipeline of novel targeted anticancer agents is rapidly expanding.
• Current drug selection strategies may not keep pace with the influx of new therapies.
• Identifying effective targeted agents for individual patients remains a challenge.

Purpose of the Study:

• To highlight the potential of molecular imaging in anticancer drug selection.
• To explore how molecular imaging can facilitate personalized cancer treatment.
• To introduce the concept of dynamic treatment tuning based on functional imaging.

Main Methods:

• Review of current challenges in targeted anticancer drug selection.
• Discussion of the role and capabilities of molecular imaging in oncology.
• Conceptual framework for integrating functional imaging into treatment protocols.

Main Results:

• Molecular imaging can significantly enhance the capacity for selecting effective targeted anticancer agents.
• Functional assessment via molecular imaging allows for early detection of treatment response or resistance.
• Dynamic treatment adjustments can be implemented based on real-time functional data.

Conclusions:

• Molecular imaging is crucial for optimizing the use of novel targeted anticancer therapies.
• Integrating functional imaging enables personalized and adaptive cancer treatment strategies.
• This approach promises to improve patient benefit from targeted anticancer agents.